178 related articles for article (PubMed ID: 2988226)
21. Use of peptides for immunization against foot-and-mouth disease.
Brown F
Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
[TBL] [Abstract][Full Text] [Related]
22. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
Vasantha S; Antony A; Lal SM
Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
[TBL] [Abstract][Full Text] [Related]
23. [Possibilities and limits of immunochemical methods (radio- and enzyme immunoassay) in testing foot-and-mouth disease vaccine].
Schilow WF; Reimann I
Arch Exp Veterinarmed; 1984 Sep; 38(5):697-703. PubMed ID: 6099107
[No Abstract] [Full Text] [Related]
24. Experiments on an early protection against foot-and-mouth disease virus.
Liebermann HT; Thalmann G; Bartels T; Nöckler A
Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
[TBL] [Abstract][Full Text] [Related]
25. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
Dimitriadis IA
Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
[TBL] [Abstract][Full Text] [Related]
26. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge.
Pay TW; Hingley PJ
Vaccine; 1992; 10(10):699-706. PubMed ID: 1326146
[TBL] [Abstract][Full Text] [Related]
27. Current status of foot-and-mouth disease vaccines including the use of genetic engineering.
Della-Porta AJ
Aust Vet J; 1983 May; 60(5):129-35. PubMed ID: 6311153
[No Abstract] [Full Text] [Related]
28. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
Morgan DO; Moore DM
Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
[TBL] [Abstract][Full Text] [Related]
29. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
[TBL] [Abstract][Full Text] [Related]
30. Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations.
Terpstra C; Van Maanen C; Van Bekkum JG
Res Vet Sci; 1990 Sep; 49(2):236-42. PubMed ID: 2173088
[TBL] [Abstract][Full Text] [Related]
31. Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines.
Doel TR
Rev Sci Tech; 1996 Sep; 15(3):883-911. PubMed ID: 9025140
[TBL] [Abstract][Full Text] [Related]
32. [Detection of neutralizing antibodies in calves after single vaccination against foot-and-mouth disease virus type ASIA 1 in the field].
Dimitriadis I; Chondrokouki E
Berl Munch Tierarztl Wochenschr; 1991 Sep; 104(9):313-6. PubMed ID: 1659374
[TBL] [Abstract][Full Text] [Related]
33. Estimation of maternally acquired immunity in suckling mice to evaluate foot-and-mouth disease vaccine.
Strobbe R; de Clercq K; Debecq J
Arch Exp Veterinarmed; 1988 May; 42(3):410-3. PubMed ID: 2845880
[No Abstract] [Full Text] [Related]
34. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.
Pay TW; Hingley PJ
Vaccine; 1987 Mar; 5(1):60-4. PubMed ID: 3033928
[TBL] [Abstract][Full Text] [Related]
35. Potency assessment of foot-and-mouth disease vaccines in cattle by means of antibody assays.
Amadori M; Archetti IL; Tollis M; Buonavoglia C; Panina GF
Biologicals; 1991 Jul; 19(3):191-6. PubMed ID: 1659429
[TBL] [Abstract][Full Text] [Related]
36. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
Alonso A; Darsie GC; Teixeira AC; Reis JL; Mesquita JA
Vaccine; 1994 Jun; 12(8):682-6. PubMed ID: 8091844
[TBL] [Abstract][Full Text] [Related]
37. Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines.
Doel TR; Collen T
J Biol Stand; 1982 Apr; 10(2):69-81. PubMed ID: 6284761
[No Abstract] [Full Text] [Related]
38. [An alternative method for the control of anti-aphthae vaccines].
Leunen J; Strobbe R
Bull Mem Acad R Med Belg; 1986; 141(5-6):335-42. PubMed ID: 3026535
[No Abstract] [Full Text] [Related]
39. [Current status of immunoprophylaxis against foot-and-mouth disease].
Benndorf E; Thalmann G
Arch Exp Veterinarmed; 1978; 32(3):326-36. PubMed ID: 211978
[TBL] [Abstract][Full Text] [Related]
40. [Viral vaccines produced by gene technology and synthesis].
Hess RG
Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
